Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,354,524 | $10,038,252 | $8,087,135 | $10,412,681 |
| - Cash | $789,037 | $657,099 | $347,127 | $600,889 |
| + Debt | $2,521,374 | $2,521,457 | $2,521,284 | $2,754,758 |
| Enterprise Value | $12,086,861 | $11,902,610 | $10,261,292 | $12,566,550 |
| Revenue | $850,739 | $811,085 | $706,785 | $713,424 |
| % Growth | 4.9% | 14.8% | -0.9% | – |
| Gross Profit | $583,929 | $562,453 | $500,547 | $429,224 |
| % Margin | 68.6% | 69.3% | 70.8% | 60.2% |
| EBITDA | $38,125 | $53,135 | -$38,111 | -$814,573 |
| % Margin | 4.5% | 6.6% | -5.4% | -114.2% |
| Net Income | -$19,594 | -$1,185 | -$101,215 | -$864,585 |
| % Margin | -2.3% | -0.1% | -14.3% | -121.2% |
| EPS Diluted | -0.1 | -0.006 | -0.54 | -4.67 |
| % Growth | -1,487.3% | 98.8% | 88.4% | – |
| Operating Cash Flow | $219,923 | $89,017 | $30,809 | $47,063 |
| Capital Expenditures | -$29,897 | -$42,342 | -$31,174 | -$36,316 |
| Free Cash Flow | $190,026 | $46,675 | -$365 | $10,747 |